In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Obesity pill data released by Viking Therapeutics Inc and AstraZeneca Plc at a big conference foreshadowed an increasingly ...

The pharmaceutical company Viking has recently become one of the most volatile stocks on Wall Street due to the announcement ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Those drugs include an experimental obesity pill. Astra is working to almost double sales to $80 billion and launch 20 new ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

The pill works by reducing people’s nicotine cravings ... and technology by bringing together leaders to tackle healthcare ...

Apart from its pill, Viking is developing a weight loss injection and other treatments. Meanwhile, AstraZeneca said its experimental obesity pill was well-tolerated by patients with Type 2 ...